Skip to main content

Table 2 Rates of BMD measurement, osteoporosis diagnosis, and osteoporosis medication

From: Factors influencing diagnosis and treatment of osteoporosis after a fragility fracture among postmenopausal women in Asian countries: a retrospective study

 

BMD measurement (N=1,122)

Osteoporosis diagnosis (N=1,122)

Osteoporosis medication (N=1,122)

%

P valuea

%

P valuea

%

P valuea

Total

28.2

 

51.5

 

33.0

 

Age

 

<0.001

 

0.009

  

 <50

9.8

 

17.1

 

0.0

 

 50-64

30.3

 

51.6

 

22.3

 

 ≥65

28.7

 

53.1

 

35.5

 

Fracture history

 

<0.001

 

<0.001

 

0.53

 Yes (n=174)

38.5

 

65.5

 

36.8

 

 No (n=907)

26.9

 

48.6

 

32.0

 

Payment type

 

<0.001

 

<0.001

 

<0.001

 100% self pay

19.7

 

10.9

 

23.2

 

 Partial self pay with social insurance

25.9

 

21.2

 

40.8

 

 Partial self pay with private insurance

1.4

 

1.4

 

2.2

 

 100% paid by social insurance

7.3

 

3.3

 

8.9

 

 100% paid by private insurance

1.3

 

1.0

 

2.0

 

 Hospital treatment free of charge

3.4

 

2.5

 

3.7

 

 Others

11.2

 

9.6

 

14.4

 

 Unknown insurance

29.7

 

1.6

 

4.7

 
  1. aP-value for Fisher’s exact test.